Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Central Nervous System Drugs Market Research Reports
Central Nervous System Drugs Market Research Reports
| Title | published | price | |
|---|---|---|---|
Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Major Depressive Disorder, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2500 | |
Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Brain Hemorrhage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 02-May-2022 | $2000 | |
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... yers provides an overview of the Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dravet Syndrome (Severe Myoclonic Epileps......" | 02-May-2022 | $2000 | |
Memory Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Memory Impairment, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2000 | |
Dental Pain (Toothache-Tooth Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Pain (Toothache/Tooth Pain) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dental Pain (Toothache/Tooth Pain), complete with analysis by Stage of Development, Drug Target, Mech......" | 02-May-2022 | $2000 | |
Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ized Anxiety Disorder (GAD) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), complete with analysis by Stage of Development, Drug Target, Mech......" | 02-May-2022 | $2000 | |
Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... sm (West Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Infantile Spasm (West Syndrome), complete with analysis by Stage of Development, Drug Target, Mechanism of Act......" | 02-May-2022 | $2000 | |
Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Essential Tremor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 02-May-2022 | $2000 | |
Acute Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ndscape.
The report provides comprehensive information on the therapeutics under development for Acute Ischemic Stroke, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 02-May-2022 | $2000 | |
Drug-Induced Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Drug-Induced Dyskinesia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2000 | |
| | |||